1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975–2013, National Cancer Institute. Bethesda,
https://seer.cancer.gov/csr/1975_2013/
, based on November 2015 SEER data submission, posted to the SEER web site, April 2016.
2. American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.
3. Goodwin PJ, Shepherd FA. Economic issues in lung cancer: a review. J Clin Oncol. 1998;16(12):3900–12.
4. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer. 2005;50(2):143–54.
5. American Cancer Society. Treatment choices for non-small cell lung cancer, by stage, 2017. Atlanta: American Cancer Society.
https://www.cancer.org/cancer/non-small-cell-lung-cancer/treating/by-stage.html
. Accessed 7 Nov 2017